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Carbon monoxide (CO) arises physiologically 
in cells during the oxidative catabolism of heme 
by heme oxygenase (HO) enzymes (1). HO-1, 
an inducible isoform of HO, provides a protec-
tive response to injury associated with proapop-
totic stimuli or infl  ammation (1). Both mice and 
humans defi  cient in HO-1 expression have a 
phenotype of an increased infl  ammatory  state 
(2–4). We have previously described that CO 
can not only suppress LPS-induced proinfl  am-
matory cytokine production, but also decrease 
mortality in a mouse model of sepsis (5, 6). We 
further showed that these antiinfl  ammatory 
  eff   ects of CO are mediated by the mitogen-
  activated protein kinase (MAPK) pathway 
(5, 6). However, nothing is known regarding 
the eff  ect of CO on upstream Toll-like receptor 
(TLR) signaling pathways.
TLRs are innate receptors critically in-
volved in the initial phase of microbial detection 
(7). The recognition of distinct pathogen-
  associated molecular patterns (PAMPs) by TLRs 
activates signaling pathways that induce the 
expression of proinfl  ammatory genes (7). Al-
though the immune system of TLRs contrib-
utes to host defense, the TLRs have also been 
implicated in the pathogenesis of infl  amma-
tory human diseases (7, 8). To avoid inappro-
priate hyperresponses of the immune system, 
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Carbon monoxide (CO), a byproduct of heme catabolism by heme oxygenase (HO), confers 
potent antiinfl  ammatory effects. Here we demonstrate that CO derived from HO-1 inhib-
ited Toll-like receptor (TLR) 2, 4, 5, and 9 signaling, but not TLR3-dependent signaling, in 
macrophages. Ligand-mediated receptor traffi  cking to lipid rafts represents an early event 
in signal initiation of immune cells. Traffi  cking of TLR4 to lipid rafts in response to LPS was 
reactive oxygen species (ROS) dependent because it was inhibited by diphenylene iodonium, 
an inhibitor of NADPH oxidase, and in gp91phox-defi  cient macrophages. CO selectively 
inhibited ligand-induced recruitment of TLR4 to lipid rafts, which was also associated with 
the inhibition of ligand-induced ROS production in macrophages. TLR3 did not translocate 
to lipid rafts by polyinosine-polycytidylic acid (poly(I:C)). CO had no effect on poly(I:C)-
induced ROS production and TLR3 signaling. The inhibitory effect of CO on TLR-induced 
cytokine production was abolished in gp91phox-defi  cient macrophages, also indicating a role 
for NADPH oxidase. CO attenuated LPS-induced NADPH oxidase activity in vitro, poten-
tially by binding to gp91phox. Thus, CO negatively controlled TLR signaling pathways by 
inhibiting translocation of TLR to lipid rafts through suppression of NADPH oxidase–depen-
dent ROS generation.
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the   intensity and duration of TLR signaling require tight 
regulation (7, 8).
Plasma membranes of cells contain specialized microdo-
mains called lipid rafts, which exert an important function in 
signal transduction of the immune system (9, 10). Several 
studies have demonstrated that membrane rafts play a key 
role in T cell and B cell activation by accumulating essential 
signaling molecules (9, 10). Recently, it has been apparent 
that lipid rafts are required not only for adaptive immune re-
sponses, but also for innate immune responses (10). TLR2 or 
TLR4 is recruited to membrane rafts by ligand or bacteria 
treatment (11, 12). Disruption of lipid rafts by methyl-β-
  cyclodextrin (MβCD) or nystatin inhibits proinfl  ammatory 
cytokine production (11, 12).
Here we investigated how CO aff   ects TLR signaling 
pathways in macrophages. CO negatively regulated TLR2, 
4, 5, and 9 signaling pathways, but not TLR3. Although 
TLR4 translocated to lipid rafts after LPS stimulation and 
CO suppressed its recruitment, TLR3 did not translocate to 
lipid rafts and remained in the intracellular compartment 
  after polyinosine-polycytidylic acid (poly(I:C)) stimulation 
in the absence or presence of CO. We demonstrated dif-
ferential traffi   cking patterns of TLRs to lipid rafts. CO in-
hibits traffi     cking of not only TLRs but also of adaptor 
molecules, resulting in the suppression of downstream 
  signaling pathways. Furthermore, we show that NADPH 
oxidase-dependent   reactive oxygen species (ROS) produc-
tion is involved in the translocation of TLR4 to lipid rafts by 
LPS, and that CO inhibits that traffi   cking  by  regulating 
NADPH oxidase activity.
RESULTS
Increased expression of TNF-𝗂 in HO-1−/− null mice
Because HO-1 is a well-known cytoprotective protein in-
duced by infl  ammation or oxidative stress (1), we evaluated 
the physiological properties of HO-1 in vivo by using HO-1 
null (HO-1−/−) mice. We stained kidneys and livers for CI:
A3-1 as an indicator of mouse monocytes or macrophages, 
and for TNF-α by immunohistochemistry under basal un-
treated conditions. We observed signifi  cant  infi  ltration  of 
macrophages and TNF-α expression around the convoluted 
tubules in the cortex of the kidney from HO-1−/− mice (Fig. 1, 
A and B). In contrast, immunohistochemical staining for 
macrophages and TNF-α was negligible in the kidney of 
wild-type (HO-1+/+) mice (Fig. 1, C and D). In the livers 
from HO-1−/− mice (Fig. 1 E), marked accumulation of 
macrophages was observed in the portal vein accompanied 
with cellular infi  ltration in the interlobular septum as com-
pared with in the liver from HO-1+/+ mice (Fig. 1 G). 
Kupff  er cells, which also can be stained by the CI:A3-1 
marker, are likely to represent the increased staining observed 
in the sinusoid of the liver from HO-1−/− mice relative to 
that from HO-1+/+ mice (Fig. 1, E and G). TNF-α expres-
sion was also markedly induced, consistent with localization 
of the macrophages in the liver from HO-1−/− mice (Fig. 
1 F), as compared with liver from HO-1+/+ mice (Fig. 1 H). 
In addition, increased staining for macrophages and expres-
sion of TNF-α was observed in the intestines from HO-1−/− 
mice compared with control mice (unpublished data). These 
results suggest that systemic infl  ammation is chronically in-
creased in the HO-1−/− mice (2–4), consistent with the 
known antiinfl   ammatory properties of HO-1 and the in-
volvement of HO-1 in regulating the functions of mono-
cyte/macrophages (13, 14).
Negative regulation of HO-1 in TLR signaling 
is mediated by CO
HO-1 is signifi  cantly induced by LPS (a ligand for TLR4) 
stimulation and has been shown to dampen the infl  ammatory 
eff  ects of LPS-treated models (5, 13, 14). Therefore, we ex-
amined whether HO-1 could modulate the immune response 
in various TLR signaling pathways. HO-1–overexpressing 
Figure 1.  Expression of TNF-𝗂 and macrophages in the kidneys 
and livers of HO-1 null mice. Livers and kidneys were harvested from 
HO-1 null mice (HO-1−/−; n = 3) or wild-type mice (HO-1+/+; n = 3) 
under untreated conditions, and tissue sections were immunostained 
with anti–TNF-α or anti–CI:A3-1 for the detection of macrophages/
monocytes. Representative light microscopic views are shown. Arrows 
and arrowheads indicate the infl  ux of macrophages and TNF-α expres-
sion, respectively.JEM VOL. 203, October 2, 2006  2379
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RAW 264.7 macrophages produced signifi  cantly less TNF-α 
than the control cells in response to LPS, Pam3CSK4 (a ligand 
for TLR2), and CpG (a ligand for TLR9) (Fig. 2 A; references 
5 and 6). However, when the HO-1–overexpressing cells 
were treated with LPS and hemoglobin, a scavenger of 
CO (14), the cells failed to inhibit LPS-induced TNF-α 
  production (Fig. 2 B). These data suggest that the antiinfl  am-
matory eff  ect of HO-1 on TLR signaling pathways in macro-
phages is mediated primarily by CO (5).
CO differentially inhibits TLR signaling
Because HO-1 inhibited TLR2, 4, and 9 ligand–induced 
TNF-α production (Fig. 2 A), and CO as a byproduct of 
heme catabolism by HO-1 was critically involved with the 
antiinfl  ammatory eff  ect of HO-1 (Fig. 2 B), we next investi-
gated the eff  ect of CO on various TLR ligand–induced cyto-
kine production in RAW 264.7 cells (TLR ligands; TLR2, 
peptidoglycan or Pam3CSK4 [Pam]; TLR3, double-stranded 
RNA poly(I:C); TLR4, LPS; TLR5, fl   agellin [Fla]; and 
TLR9, CpG). CO exposure signifi  cantly suppressed TLR2, 
4, 5, and 9 ligand–induced TNF-α production (Fig. 3 A), 
which is similar to the eff  ect of HO-1 observed in Fig. 2 A. 
However, CO did not aff   ect poly(I:C)-induced TNF-α 
  production (Fig. 3 A). As previously described, the eff  ect of 
CO on LPS-induced cytokine production was dose dependent 
over a range of 50–500 ppm (5, 6); however, cytokine pro-
duction by poly(I:C) was not aff  ected by CO exposure at any 
of the doses (Fig. 3 B).  To further confi  rm the eff  ect of CO 
on macrophages, mouse peritoneal macrophages were stimu-
lated with the TLR ligands in the presence or absence of 
CO. The eff  ect of CO on TNF-α production in the mouse 
peritoneal macrophages was consistent with that observed in 
RAW 264.7 macrophages (Fig. 3, A and C). Because poly
(I:C) is recognized not only by TLR3 but also by the helicase 
domain of MDA5 or RIG-I (15), we examined the relative 
role of TLR3 in poly(I:C)-induced cytokine production 
by using peritoneal macrophages from TLR3-defi  cient mice 
(tlr3−/−). Consistent with previous results (16), poly(I:C)-
  induced TNF-α production in tlr3−/− macrophages was re-
duced to nearly background levels, relative to the poly
(I:C)-induced TNF-α production observed in wild-type 
Figure 2.  Effect of HO-1 overexpression on TLR ligand–induced 
TNF-𝗂 production in macrophages. (A) RAW 264.7 cells overexpress-
ing HO-1 or control cells were treated with 100 ng/ml LPS, 100 ng/ml 
Pam, or 1 μM CpG for 1 h, and culture media were collected for TNF-α 
measurement. (B) The cells were pretreated with 5 μM of hemoglobin 
(Hb) for 30 min and stimulated with LPS for 1 h. TNF-α in culture 
  media was measured by ELISA. *, P < 0.05 and **, P < 0.01 versus 
HO-1–overexpressing cells.
Figure 3.  Effect of CO on TLR ligand–induced TNF-𝗂 production 
in macrophages. (A) RAW 264.7 cells were pretreated with 250 ppm CO 
for 2 h, followed by stimulation with the indicated concentrations of TLR 
ligands. Cell media were collected 1 or 2 h after the ligand treatment and 
TNF-α was measured by ELISA. *, P < 0.05 and **, P < 0.01 versus CO-
treated cells. (B) Cells were treated with various concentrations of CO and 
stimulated with 100 ng/ml LPS or 20 μg/ml poly(I:C) for 1 or 2 h. TNF-α 
in the culture media was measured. †, P < 0.05 and ††, P < 0.01 versus 
LPS-treated control cells. (C) Mouse peritoneal macrophages were pre-
treated with 250 ppm CO for 2 h, followed by stimulation with TLR 
  ligands for 1 or 2 h. Culture media were collected and TNF-α was measured 
by ELISA. **, P < 0.01 versus CO-treated cells. (D) Mouse peritoneal mac-
rophages from wild-type (WT) mice or TLR3-defi  cient mice (−/−) were 
stimulated with 100 ng/ml LPS or 20 μg/ml poly(I:C) for 1 or 2 h, and 
TNF-α in culture media was measured by ELISA. ††, P < 0.01 versus 
poly(I:C)-stimulated wild-type cells.2380  INHIBITION OF TLR TRAFFICKING TO LIPID RAFTS BY CO | Nakahira et al.
macrophages (Fig. 3 D). On the other hand, as expected, the 
levels of LPS-induced TNF-α production were comparable 
in wild-type and tlr3−/−macrophages (Fig. 3 D). Activation 
of both TLR3 and TLR4 signaling cascades induces IFN-β 
through the activation of IFN regulatory factor 3 (IRF-3), 
leading to the production of IFN-inducible gene products, 
such as IFN-γ–inducible protein 10 (IP-10) and the regulated 
upon activation, normal T expressed, and presumably se-
creted protein (RANTES; references 17 and 18). Although 
CO signifi  cantly inhibited LPS-induced IFN-β gene expres-
sion and the production of IP-10 and RANTES, the induc-
tion of these cytokines by poly(I:C) was not inhibited by CO 
(Fig. 4, A and B).
CO modulates transcription factor activation by TLR ligands, 
but not by poly(I:C)
Both NF-κB and IRF-3 are key transcription factors 
  activated in TLR3 and TLR4 signaling pathways (7, 16). 
Because CO inhibited the TLR ligand–induced (except 
TLR3) cytokine production, we next examined the eff  ect 
of CO on the ligand-induced activation of NF-κB and 
IRF-3. CO inhibited LPS-induced NF-κB activation as 
described pre  viously (19), and Pam-, Fla-, and CpG-in-
duced NF-κB   activation was also signifi  cantly suppressed 
by CO (Fig. 5, A and B). Translocation of IRF-3 to the 
nuclear fraction increased after LPS treatment (18), and CO 
signifi  cantly suppressed its translocation (Fig. 5 C). How-
ever, CO had no eff  ect on poly(I:C)-induced NF-κB acti-
vation and translocation of IRF-3 (Fig. 5). Consistent with 
the eff  ect of CO on TLR ligand–induced cytokine produc-
tion (Figs. 3 and 4), CO inhibited the activation of tran-
scriptional factors by LPS, but not by poly(I:C) (Fig. 5). 
These results indicate that CO diff  erentially regulates TLR 
signaling pathways.
CO suppresses the interactions of TLR4 
and adaptor molecules
With the exception of TLR3, all the TLRs interact with an 
adaptor protein, MyD88 (7). TLR3 uses only the adaptor 
molecule TIR domain–containing adaptor-inducing IFN-β 
(TRIF) to activate IRF-3, and TLR4 also activates IRF-3 
through TRIF. To investigate the eff  ect of CO on upstream 
events in TLR signaling pathways, we assessed the eff  ect of 
CO on interactions of TLRs and adaptor molecules that are 
subsequently induced after ligand binding to TLR (7, 8). We 
observed increased interaction not only between TLR4 and 
MyD88 but also between TLR4 and TRIF at 5 min after LPS 
treatment (20); however, CO markedly attenuated both inter-
actions (Fig. 6 A). Although poly(I:C) treatment also increased 
the interaction of TLR3 and TRIF, CO did not suppress the 
TLR3 and TRIF interaction (Fig. 6 B). These experiments 
support the notion that the negative regulation of CO on 
TLR signaling pathways is likely to be dependent not on 
adaptor proteins, but on the specifi  city of TLRs.
CO regulates translocation of TLRs to lipid rafts
Membrane rafts are involved with TLR signaling, including 
the activation of NF-κB and cytokine production (11, 21). 
To further address the involvement of lipid rafts on TLR 
signaling pathways and the potential role of CO on the 
membrane rafts, cells were stimulated with LPS or poly(I:C)   
Figure 4.  Effect of CO on IRF-3–related cytokine production in 
macrophages. (A) RAW 264.7 cells were treated with 100 ng/ml LPS or 
20 μg/ml poly(I:C) in the absence or presence of CO, and their IFN-β 
mRNA expression at the indicated time points was analyzed by real-time 
RT-PCR. (B) IP-10 and RANTES production in culture media was analyzed 
by ELISA. **, P < 0.01 versus CO-treated cells.  Figure 5.  CO inhibits activation of NF-𝗋B and nuclear transloca-
tion of IRF-3 by LPS, but not by poly(I:C). RAW 264.7 cells were stim-
ulated with 100 ng/ml LPS, 100 ng/ml Pam, 10 ng/ml Fla, 1 μM CpG, and 
20 μg/ml poly(I:C) in the presence or absence of CO. Nuclear protein was 
extracted for NF-κB activation assay or Western blot analysis. (A) NF-κB 
(p65) activation was analyzed by ELISA-based kits. **, P < 0.01 versus 
CO-treated cells. (B) NF-κB was analyzed by electrophoretic mobility shift 
assay. Protein–DNA complexes are shown. Arrowhead indicates nonspe-
cifi  c bands. (C) Nuclear extract was analyzed by immunoblotting for IRF-3 
nuclear translocation, followed by stripping and reprobing for upstream 
stimulatory factor 2 (USF2).JEM VOL. 203, October 2, 2006  2381
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in the presence or absence of CO and incubated with FITC–
cholera toxin (CTx). CTx specifi  cally binds to the glyco-
sphingolipid 1 (GM1), which is enriched in lipid rafts (22, 
23). In the resting RAW 264.7 cells, the distribution of 
GM1 on the plasma membrane was quite homogeneous and 
TLR4 localized, in a diff  use manner, both in the membrane 
and intracellular compartment (Fig. 7 A; reference 21). After 
LPS treatment, a large fraction of TLR4 translocated to the 
plasma membrane, and colocalization of TLR4 and GM1 
was also observed (Fig. 7 A). In CO-treated cells, the LPS-
induced translocation of TLR4 to the membrane rafts was 
signifi  cantly inhibited (Fig. 7 A). In contrast, TLR3 local-
ized in the intracellular compartment in the resting cells 
(Fig. 7 A), which is consistent with previous results (17, 24), 
and remained unchanged after poly(I:C) stimulation, even 
when CO was added (Fig. 7 A). The localization of TLR4 
and TLR3 did not change in the cells treated with CO alone 
(unpublished data). Next, cells were incubated with FITC-
CTx and cross-linked with anti-CTx. CTx specifi  cally binds 
to the GM, and GM1-CTx can be crossed-linked to mem-
brane patches with anti-CTx (22, 23, 25). These membrane 
patches have properties that are similar to those of biochem-
ically isolated rafts (22, 23, 25).Without anti-CTx cross-
linking, distribution of GM1 on the plasma membrane was 
homogeneous and TLR4 was expressed in a diff  use manner 
(Fig. S1 A, available at http://www.jem.org/cgi/content/
full/jem.20060845/DC1). After the anti-CTx cross-linking 
at 37°C, a large part of GM1 translocated to a crescent-shaped 
patched area in the plasma membrane and a large fraction of 
TLR4 also translocated to the same area. Colocalization 
of TLR4 and GM1 was observed (Fig. S1 A). In contrast, 
TLR3 remained unchanged in the cytosolic fraction, not in 
the crescent-shaped patched area, after the cross-linking at 
37°C (Fig. S1 B). To further investigate whether CO modu-
lates the translocation of TLR4 and its adaptor molecules to 
lipid rafts, we isolated raft fractions and examined the trans-
location of the proteins involved in TLR   signaling by im-
munoblotting. Flotillin-1, constitutively expressed in lipid 
rafts (26), localized in fractions 3 and 4. LPS or CO treat-
ment had no eff  ect on its abundance among the sucrose den-
sity fractions (Fig. 7 B). Most of GM1 localized in the same 
fractions (Fig. 7 B) and no alteration of the distribution was 
observed by LPS or CO treatment (unpublished data; 
references 11 and 27). TLR4 and its adaptor molecules 
(MyD88 and TRIF), as well as MD-2, IL-1 receptor–associ-
ated kinase, TNF receptor–associated factor (TRAF)-6, p65, 
and IκB-α, rapidly translocated to lipid rafts after LPS stimu-
lation (11, 27), whereas TRAF-2 was not translocated (Fig. 
7 B). In contrast, CO signifi  cantly inhibited the LPS- induced 
recruitment of TLR4 and other signaling molecules to lipid 
rafts (Fig. 7 B). The distribution of TLR4 was not aff  ected 
by CO treatment alone (Fig. 7 B). Consistent with other 
data (11), CD-14 was constitutively expressed mainly in 
lipid rafts of resting cells and its expression was unaff  ected by 
LPS or CO treatment (Fig. 7 B). To confi  rm the diff  erential 
localization and translocation patterns of TLRs, TLR3, 4, 
and 9 were immunoprecipitated with each antibody and 
  immunoblotted with the same antibody using Triton X-100 
soluble and insoluble raft fractions. After the ligand stimula-
tion, TLR4 and TLR9 translocated to the rafts fraction, 
whereas TLR3 did not (Fig. 7 C). In addition, the adaptor 
protein TRIF interacted with TLR4 in the rafts fraction by 
LPS stimulation, but not with TLR3 by poly(I:C) (Fig. 7 C). 
These results confi   rm the diff   erential translocation of TLRs 
to lipid rafts by ligand stimulation and agree with our immuno-
fl  uorescence data (Fig. 7 A and Fig. S1). To examine the 
role of lipid rafts as a platform of ligand-induced TLR acti-
vation, we pretreated cells with MβCD and stimulated them 
with LPS, Pam, or poly(I:C). Although LPS- or Pam-
  induced TNF-α production was signifi  cantly reduced by 
MβCD treatment, poly(I:C)-induced cytokine production 
was unaff  ected (Fig. 7 D; references 11 and 28). In contrast, 
pretreatment of monodansylcadaverine (MDC), an inhibitor 
of the clathrin-dependent internalization pathway (29), 
markedly suppressed TNF-α production by poly(I:C) treat-
ment, but not by LPS or Pam in macrophages (Fig. 7 E). 
These data suggest that the involvement of lipid rafts in TLR 
signaling is dependent on the specifi  city of the TLRs.
Inhibition of ROS generation by CO suppresses traffi  cking 
of TLR to rafts
ROS are known to be critical in intracellular signaling, includ-
ing the TLR signaling pathway, and the scavenging of ROS 
Figure 6.  Effect of CO on interactions of TLRs and adaptor mol-
ecules. RAW 264.7 cells were treated with 100 ng/ml LPS or 20 μg/ml 
poly(I:C) in the absence or presence of CO. (A) Interaction between TLR4 
and MyD88 or TLR4 and TRIF was analyzed with immunoprecipitation and 
immunoblotting. Expression of TLR4, MyD88, and TRIF was analyzed by 
immunoblotting using total cell lysates. (B) Interaction of TLR3 and TRIF 
was analyzed with immunoprecipitation and immunoblotting.2382  INHIBITION OF TLR TRAFFICKING TO LIPID RAFTS BY CO | Nakahira et al.
Figure 7.  Lipid rafts are involved with TLR signaling, but not 
TLR3. (A) RAW 264.7 cells were stimulated with LPS or poly(I:C) in 
the presence or absence of CO for 1 h, followed by incubation of FITC-
CTx on ice for 10 min. Cells were analyzed for FITC-CTx–stained GM1 
(green) and TLR4 or TLR3 (red) by confocal microscopy. (B) RAW 264.7 
cells were stimulated with LPS in the presence or absence of CO for 
5 min. Cell lysates were fractionated by sucrose-gradient ultracentrifu-
gation, followed by fractionation to 12 subfractions for immunoblot-
ting with fl  otillin-1, TLR4, and other signaling proteins. (C) RAW 264.7 
cells were treated with LPS, CpG, or poly(I:C) for 1 h, and then lipid 
raft fractions (fractions 3 and 4) and nonraft fractions (fractions 9–12) 
were separated. TLR3, 4, or 9 was immunoprecipitated with anti-TLR3, 
4, or 9 mAb from raft fractions or nonraft fractions, followed by 
immuno  blotting with the anti-TLR3, anti-TLR4, or anti-TRIF mAb. 
(D) RAW 264.7 cells were pretreated with 15 mM MβCD or medium 
for 15 min, followed by stimulation with LPS, Pam, or poly(I:C) for 1 or 
2 h. Cell media were harvested and TNF-α production was analyzed by 
ELISA. *, P < 0.05 versus MβCD-treated cells. (E) RAW 264.7 cells were 
pretreated with 200 μM MDC or methanol as vehicle for 30 min, and 
then stimulated with LPS, Pam, or poly(I:C) for 1 or 2 h. TNF-α produc-
tion in cell media was analyzed by ELISA. **, P < 0.01 versus MDC-
treated cells.JEM VOL. 203, October 2, 2006  2383
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or the inhibition of NADPH oxidase suppresses LPS-induced 
cytokine production (30, 31). To examine if ROS are in-
volved with the TLR signaling pathway and traffi   cking of 
TLR to lipid rafts, RAW 264.7 cells were pretreated with the 
antioxidant N-acetyl-l-cysteine (NAC) or a NADPH oxidase 
inhibitor, diphenylene iodonium (DPI), for 30 min, followed 
by incubation with TLR ligands. NAC and DPI suppressed 
LPS-induced TNF-α production in a dose-dependent manner 
(Fig. 8 A), and DPI signifi  cantly suppressed TNF-α produc-
tion induced by LPS, Pam, and CpG, but not by poly(I:C) 
treatment (Fig. 8 B). DPI also inhibited LPS-induced interac-
tion of TRIF and TLR4 (Fig. 8 C). In addition, we observed 
that the LPS-induced translocation of TLR4 to lipid rafts was 
inhibited by DPI treatment (Fig. 8 D). These results indicate 
that inhibition of NAPDH oxidase suppresses the TLR signal-
ing pathway by modulating events upstream of the pathway. 
Furthermore, cellular stimulation with H2O2 and PMA also 
recruit TLR4 to lipid rafts (Fig. 8 E), which is consistent with 
previously reported results (32). To investigate the involve-
ment of CO on TLR ligand–induced ROS generation, we 
detected TLR ligand–induced ROS production by using a 
fl  uorescence probe. CO signifi  cantly suppressed not only LPS- 
but also Pam-induced ROS production (Fig. 9 A). However, 
CO failed to inhibit poly(I:C)-induced ROS production in 
macrophages (Fig. 9 A). Upon stimulation, ROS are gener-
ated by NADPH oxidase, which forms a membrane-bound 
complex, including p22phox and gp91phox (cytochrome b558) 
and cytosolic proteins such as p47phox (33, 34). The complex of 
gp91phox and p47phox started to increase 5 min after LPS treat-
ment, whereas complex formation was inhibited by CO as 
well as DPI treatment (Fig. 9 B). Furthermore, superoxide an-
ion production, detected in isolated membrane fractions from 
LPS-treated macrophages, was inhibited when the cells were 
also exposed to CO (Fig. 9 C). Because CO is known to bind 
to heme proteins such as hemoglobin (1), we asked whether 
CO may interact with gp91phox, a heme protein (34, 35). To 
address this question, we partially purifi  ed cytochrome b558 
from bovine neutrophils and performed a spectral analysis. 
An oxidized spectrum was observed with a major peak at 
410 nm. Heme proteins show major peak of absorption 
  spectra typically at 400–450 nm and minor peaks in the range 
of 500–650 nm (35, 36). After incubation of the extract 
with sodium   dithionite, the major peak shifted to 421 nm, 
generating distinct diff   erence spectra (Fig. S2, available at 
http://www.jem.org/cgi/content/full/jem.20060845/DC1). 
Exposure of CO to the dithionite-reduced form of cyto-
chrome b558 extract decreased the absorption peak and shifted 
the major peak from 421 to 418 nm, generating distinct 
Figure 8.  ROS generation is involved with translocation of TLR4 
to lipid rafts. (A) RAW 264.7 cells were pretreated with the indicated 
concentration of NAC or DPI for 30 min, followed by incubation with LPS 
for 1 h. TNF-α production in cell media was analyzed by ELISA. †, P < 0.05 
and ††, P < 0.01 versus LPS-treated control cells. (B) RAW 264.7 cells were 
pretreated with 2 μM DPI, followed by incubation with LPS, Pam, CpG, or 
poly(I:C) for 1 or 2 h. TNF-α production in cell media was analyzed by 
ELISA. **, P < 0.01 versus DPI-treated cells. (C) RAW 264.7 cells were pre-
treated with 2 μM DPI or DMSO as vehicle for 30 min, followed by incuba-
tion with 100 ng/ml LPS. Interaction between TLR4 and TRIF was analyzed 
with immunoprecipitation assay. (D and E) RAW 264.7 cells were pretreated 
with 2 μM DPI for 30 min, followed by incubation with 100 ng/ml LPS, 
100 μM H2O2, or 1 μM PMA for 1 h. Cell lysates were fractionated to 12 
subfractions, followed by immunoblotting for TLR4 and fl  otillin-1.2384  INHIBITION OF TLR TRAFFICKING TO LIPID RAFTS BY CO | Nakahira et al.
Figure 9.  CO inhibits LPS-induced TLR4 traffi  cking by inhibiting 
NADPH oxidase activity. (A) RAW 264.7 cells were incubated with 
100 ng/ml LPS, 100 ng/ml Pam, and 20 μg/ml poly(I:C) in the presence or 
absence of CO after preincubation with 10 μM CM-H2DCFDA for 30 min. 
Fluorescence intensity of the cells was measured as the amount of ROS 
accumulation (left). Representative images are shown from three inde-
pendent experiments (right). *, P < 0.05 and **, P < 0.01 versus CO-
treated cells. (B) RAW 264.7 cells were treated with LPS in the presence or 
absence of CO or DPI. Interaction of gp91phox and p47phox was analyzed by 
immunoprecipitation assay. (C) RAW 264.7 cells were treated with LPS for 
30 min in the presence or absence of CO or DPI. Superoxide production 
was analyzed by determining the reduction rate of acetylated cytochrome 
C. ††, P < 0.01 versus LPS-treated control cell. (D) Cytochrome b558 
  fraction was isolated from bovine neutrophils and the spectra of cytochrome 
b558 were analyzed. The isolated oxidized cytochrome b558 was reduced 
by adding 5 mM of sodium dithionite and CO was bubbled for 30 s, fol-
lowed by spectra analysis (left). The spectral difference between the con-
trol (Reduced form) and CO-treated sample (CO Reduced) was shown 
(right). (E) Peritoneal macrophages were isolated from gp91phox-defi  cient 
(gp91phox−/−) mice and wild-type (WT) mice. Cells were exposed to LPS for 
1 h in the presence or absence of CO. TNF-α production in cell media was 
analyzed by ELISA. ††, P < 0.01 versus air/LPS (WT). **, P < 0.01 versus 
air/LPS (WT). (F and G) RAW 264.7 cells were stimulated with LPS in the 
presence or absence of DPI or CO, and the interaction of TLR4 and gp91phox 
was analyzed using immunoprecipitation assay. (H) Peritoneal macro-
phages from gp91phox-defi  cient and wild-type mice were stimulated with 
100 ng/ml LPS for 5 min. Cell lysates were fractionated to 12 subfractions, 
followed by immunoblotting for TLR4 and GM1.JEM VOL. 203, October 2, 2006  2385
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  diff  erence spectra (Fig. 9 D). To elucidate the functional role 
of NADPH oxidase in TLR signaling, peritoneal macro-
phages from gp91phox-defi  cient (gp91phox−/−) mice were ex-
posed with LPS in the presence or absence of CO. Cells from 
gp91phox−/− mice signifi  cantly produced less TNF-α in re-
sponse to LPS than the cells from the wild-type control (37). 
The eff  ect of CO on LPS-induced TNF-α production was 
impaired in gp91phox-defi  cient cells (Fig. 9 E). In addition, we 
examined the interaction of TLR4 and gp91phox by LPS. 
TLR4 interacted with gp91phox in response to LPS treatment, 
whereas DPI treatment inhibited the interaction (Fig. 9 F). 
CO inhibited the LPS-induced complex formation of TLR4 
and gp91phox (Fig. 9 G). Finally, to confi  rm if NADPH oxi-
dase is involved in the LPS-induced translocation of TLR4 to 
lipid rafts, we isolated lipid rafts from peritoneal macrophages 
from gp91phox−/− mice. TLR4 translocated to lipid rafts 5 min 
after LPS treatment in the wild-type cells; however, the translo-
cation of TLR4 by LPS was suppressed in gp91phox-defi  cient 
cells (Fig. 9 H). These results suggest that gp91phox is involved 
with LPS-induced translocation of TLR4 to lipid rafts and 
that the eff  ect of CO on traffi   cking to lipid rafts is potentially 
mediated by the modulation of gp91phox and the suppression 
of NADPH oxidase activity, leading to the inhibition of traf-
fi  cking of TLR4 to lipid rafts.
DISCUSSION
Although several negative regulators of TLR signaling have 
been reported (8), there are few reports that the modulation 
of TLR traffi   cking to lipid rafts correlates with the regulation 
of TLR signaling, and that elucidate the mechanism of traf-
fi  cking (27). Here we demonstrate that TLRs show diff  eren-
tial patterns of traffi   cking after TLR ligand stimulation, and 
that NADPH oxidase is critically involved with translocation 
of TLR4 to lipid rafts and downstream TLR signaling. Our 
results showed that TLR4 translocated to lipid rafts by LPS, 
whereas TLR3 remained in the intracellular compartment 
  after poly(I:C) treatment. In addition, CO signifi  cantly sup-
pressed LPS-induced ROS generation, resulting in the inhi-
bition of the recruitment of TLR4 to the rafts and of 
downstream pathways, including activation of transcription 
factors and cytokine production. In contrast, CO failed to 
regulate the TLR3 signaling pathway. Thus, CO diff  erentially 
regulated TLR signaling pathways.
CO negatively regulated TLR2, 4, 5, and 9 signaling 
pathways as revealed by the inhibition of cytokine produc-
tion and the inactivation of transcription factors (Figs. 3–5). 
In addition, the eff  ect of CO was exerted at the initial signal-
ing events, TLR4–MyD88 or TLR4–TRIF complex formation 
(Fig. 6). In contrast, CO had no eff  ect on poly(I:C)-induced 
TLR3 signaling pathways from complex formation of TRIF 
and TLR3 to cytokine production (Figs. 3–6), which is con-
sistent with the observation that HO-1–overexpressing cells 
failed to suppress poly(I:C)-induced cytokine production 
(unpublished data). Although recent studies show that the 
cytoplasmic proteins RIG-I and MDA5 have also been iden-
tifi  ed as double-stranded RNA detectors (15, 38), our results 
demonstrate that TLR3 plays the dominant role in poly(I:C)-
induced cytokine production at early time points in macro-
phages (Fig. 3 D; reference 16). It has been shown that several 
molecules act as negative regulators in multiple TLR signal-
ing pathways and some of them exert their eff  ects on the 
level of receptor or adaptor proteins (8). ST2 negatively reg-
ulates TLR2, 4, and 9, but not TLR3 signaling (39), which 
is similar with the diff  erential eff  ect of CO. Although ST2 
suppresses TLR4 signaling by sequestration of the adaptor 
protein MyD88 and Mal, but not TRIF (39), CO inhibited 
the LPS-induced interaction of TLR4 and TRIF as well as of 
TLR4 and MyD88. Although Triad3A also negatively regu-
lates TLR4- and TLR9-mediated signal activation, it has 
no eff  ect on the TLR2 signaling pathway (40). Thus, the 
mechanism of negative regulation by CO on TLR signaling 
pathways is likely to be independent of the type of adaptor 
molecules as well as transcription factors, but dependent on 
the specifi  city of TLRs.
Our studies have shown that translocation of TLRs to 
lipid rafts is also dependent on their diversity (11, 12). Al-
though IκB kinase α/β and IκB-α are recruited to the lipid 
rafts in B cell signaling (41), our data showed that LPS stimu-
lation increased the traffi   cking of not only TLR4 but also 
other important signaling molecules in TLR signaling path-
ways to the raft membrane in macrophages (Fig. 7 B). This 
conclusion is supported by previous fi  ndings that MyD88 is 
translocated from cytosolic fraction to membrane fraction by 
LPS in RAW 264.7 cells (29). We showed that TRAF-6, a well-
known important molecule in TLR signaling, translocated 
to the rafts 5 min after LPS stimulation, whereas TRAF-2 
did not (Fig. 7 B). The diff  erential traffi   cking patterns of 
TRAF-2 and TRAF-6 may be dependent on the specifi  city 
of ligand stimulation. In a similar fashion, CD40 engagement 
resulted in diff   erential translocation patterns, such that 
TRAF-2 translocated to lipid rafts but TRAF-6 did not (42). 
We showed that CpG stimulation translocated TLR9 to 
membrane rafts (Fig. 7 C), similar to the previous observation 
that a small portion of TLR9 becomes cell surface accessible 
after CpG treatment (43). Together with previous results on 
the localization of TLR9 (43, 44), the recognition of CpG by 
TLR9 is likely to occur not only in the intracellular compart-
ment but also in lipid rafts where TLR9 presumably clusters 
from cytosol after CpG stimulation in macrophages. Lipid 
rafts cross-linked with anti-CTx antibody immediately in-
crease intracellular Ca2+, which is up-regulated by ROS 
stimulation and which is required for the traffi   cking of mole-
cules from the cytosolic compartment to the plasma mem-
brane (32, 45, 46). Although cross-linking with anti-CTx 
causes signaling events analogous to activation of T cell re-
ceptor signaling (22, 23, 45), the results suggest that cross-
linking by anti-CTx at 37°C is likely to provoke traffi   cking 
of TLR4 to the crescent-shaped membrane patch similar to 
biochemically isolated rafts. Although the cross-linking at 
37°C showed translocation of TLR4 to the crescent-shaped 
patched area, TLR3 remained in the intracellular compart-
ment (Fig. S1, A and B). These diverse patterns of TLRs 2386  INHIBITION OF TLR TRAFFICKING TO LIPID RAFTS BY CO | Nakahira et al.
traffi   cking by the cross-linking are very similar to those by 
TLR ligand stimulation (Fig. 7, A and C). Moreover, the ef-
fect of MβCD and MDC on poly(I:C)-induced TNF-α pro-
duction was opposite to the responses to LPS or Pam (Fig. 7, 
D and E). The signaling events of TLR3 are unlikely to   occur 
in the raft membrane (17, 24), whereas the rafts are involved 
with the other TLR signaling pathways (11, 12).
Despite several results about the involvement of ROS in 
TLR signaling (30, 31), the role of ROS on traffi   cking to 
lipid rafts and on TLR signaling is still unclear. ROS such as 
superoxide or hydrogen peroxide are known to regulate acti-
vation of NF-κB or cytokine production (30, 31). We showed 
that LPS-induced NADPH oxidase–dependent ROS genera-
tion is critically involved in the translocation of TLR4 to lipid 
rafts and the initiation of the TLR signaling pathway. Fur-
thermore, not only stimulation with hydrogen peroxide but 
also PMA, a potent NADPH oxidase activator (Fig. 9 C), can 
recruit TLR4 to lipid rafts (Fig. 8 E). Powers et al. (32) have 
reported that oxidative stress induced by hemorrhagic shock 
recruits TLR4 to the plasma membrane in macrophages. The 
present study shows that NADPH oxidase–dependent ROS 
generation induced by TLR ligand stimulation plays a critical 
role in the traffi   cking of TLR to lipid rafts and the initiation 
of downstream signaling pathways. In addition, the results 
suggest that the inhibitory eff  ect of CO on the translocation 
of TLR4 to membrane rafts and on TLR signaling is medi-
ated through the inhibition of NADPH oxidase activity. We 
observed similar diff  erential eff  ects of DPI and CO on TLR 
ligand–induced TNF-α production (Figs. 3 A and 8 B). In 
addition, we showed that CO signifi  cantly inhibited ROS 
production induced by LPS (47) and Pam, but not by poly(I:C), 
which is similar to the above data (Figs. 3 A and 9 A). Two 
integral membrane proteins, gp91phox and p22phox, form a sta-
bilizing complex, termed cytochrome b558, and heme incor-
poration into gp91phox is essential for the heterodimer formation 
(34). Recent studies showed that CO modulates the activity 
of heme proteins such as a potassium channel and soluble gua-
nylate cyclase (1, 35, 48). Our spectral results also suggest that 
CO may form a complex with cytochrome b558 (Fig. 9 D). 
One of the critical roles of NADPH oxidase in professional 
immune cells is to generate ROS as a defense against invading 
microorganisms. It is known that gp91phox-defi  cient humans, 
such as patients with chronic granulomatous disease, lack the 
ability to produce ROS, including superoxide (34). Our data 
showed that LPS-induced TNF-α production was signifi  -
cantly suppressed in macrophages from gp91phox-defi  cient 
mice. In addition to this physiological importance of gp91phox 
on LPS-induced proinfl  ammatory cytokine production, we 
demonstrated LPS-induced interaction between gp91phox and 
TLR4 by using immunoprecipitation analysis (Fig. 9 F). DPI, 
an NADPH oxidase inhibitor, suppressed this interaction as 
well as inhibited LPS-induced TLR4 signaling and cytokine 
production (Fig. 8, A–C). These results confi  rm a crucial link 
between gp91phox and TLR4 signaling pathways. Consistent 
with previous results (47, 49), we showed that CO inhibits 
LPS-induced superoxide generation, associated with NADPH 
oxidase activation, in the membrane fraction of macrophages 
(Fig. 9 C). Furthermore, our results indicate that CO inhib-
ited LPS-induced complex formation of gp91phox and p47phox, 
which is essential for assembling the active complex of 
NADPH oxidase (Fig. 9 B). The possible interaction of CO 
with cytochrome b558 may inhibit complex formation with 
cytosolic NADPH oxidase components. We showed that not 
only inhibition of NADPH oxidase activity but also lack of 
gp91phox abolished the traffi   cking of TLR4 to the rafts by LPS 
(Figs. 8 D and 9 H). These results suggest that CO inhibits 
LPS-induced translocation of TLR4 to lipid rafts by inhibit-
ing NADPH oxidase activity. Moreover, our results indicate 
that CO is likely to modulate gp91phox, which is supported by 
the following observations: CO failed to suppress LPS-
  induced TNF-α production in gp91phox-defi  cient macro-
phages; CO inhibited LPS-induced complex formation of 
gp91phox and TLR4; and CO can form a complex with b558 
in vitro (Fig. 9, D, E, and G).
Negative regulation of TLR signaling pathways by CO is 
likely to be mediated by the modulation of traffi   cking of 
TLRs to membrane rafts, and CO inhibits the traffi   cking by 
inhibition of NADPH oxidase activity, potentially through 
gp91phox. First, CO suppressed TLR4 signaling, but not TLR3 
(Figs. 3–6). Second, LPS stimulation rapidly translocated 
TLR4 to lipid rafts, but TLR3 did not translocate to the rafts 
in response to poly(I:C) as revealed by immunoblotting and 
immunofl   uorescence studies (Fig. 7, A–C). Third, CO 
blocked LPS-induced recruitment of TLR4 and other signal-
ing molecules to lipid rafts (Fig. 7 B). Finally, CO suppressed 
LPS-induced ROS production including superoxide pro-
duction (Fig. 9, A and C), and this eff  ect of CO was impaired 
in gp91phox-defi  cient cells (Fig. 9 E). Thus, ROS generated 
through NADPH oxidase activation is critically involved in 
signal transduction of TLRs in lipid rafts.
Recent studies in HO-1–defi  cient humans and mice pro-
vide the strongest evidence that HO-1 is a crucially impor-
tant molecule in host defense against oxidative stress induced 
by various stimuli including LPS (2–4). Against invading 
PAMPs from microorganisms, macrophages dominantly con-
tribute to the production of proinfl  ammatory mediators (50). 
The high expression of TNF-α in the macrophages of 
HO-1−/− mice (Fig. 1) and negative regulatory eff  ects of HO-1 
on TLR ligand–induced TNF-α production in the macro-
phages (Fig. 2 A) suggest that HO-1 is likely to be an impor-
tant molecule in regulating the activation of immune cells. 
Although biliverdin, the other byproduct of HO-1, also has 
cytoprotective eff  ects (1), our results showed that scavenging 
CO by hemoglobin abolished the eff  ect of HO-1 in TLR 
signaling (Fig. 2 B). Thus, HO-1 has a potent antiinfl  amma-
tory role in TLR-mediated immune responses, and that role 
is mainly mediated through HO-1–derived CO (5, 14).
In summary, we have demonstrated that TLR traffi   ck-
ing evoked by ligand stimulation diff  erentially occurred and 
that HO-1–derived CO negatively regulated TLR signal-
ing pathways by the inhibition of TLRs traffi   cking to mem-
brane rafts, resulting in suppression of downstream signaling JEM VOL. 203, October 2, 2006  2387
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and cytokine production. In addition, CO inhibited traf-
fi  cking of TLR by suppressing NADPH oxidase–depen-
dent ROS generation. Because excessive infl   ammatory 
mediator production during sepsis causes severe tissue dam-
age or organ dysfunction beyond essential host defense 
function (51), it is critically important to control ROS pro-
duction as a key cell signaling activator in the immune sys-
tem. The present study suggests that CO, a gas molecule 
produced physiologically in cells, might have a potent role 
to regulate PAMP-induced proinfl   ammatory cascades by 
modulating ROS generation, resulting in the suppression 
of inappropriate hyperreactive immune responses. We have 
previously reported that the eff  ect of CO on LPS-induced 
cytokine production is mediated by p38 MAPK (5), and 
recent results have suggested another mechanism of CO on 
the LPS-induced infl  ammatory response, which is mediated 
by PPAR-γ (52). However, these results do not address 
the involvement of MAPK and PPAR-γ in the traffi   cking 
of TLR to lipid rafts. Although further studies are needed 
to investigate the precise mechanisms of CO action, our 
results show that CO is a novel candidate as a negative reg-
ulator in TLR signaling pathways.
MATERIALS AND METHODS
Cell culture. RAW 264.7 cells and mouse peritoneal macrophages were 
maintained in DMEM containing 10% fetal bovine serum and antibiotics 
(5). For CO treatment, CO at a concentration of 1% corresponding to 
10,000 ppm in compressed air was mixed with compressed air containing 
5% CO2 before delivery into the exposure chamber as described previ-
ously (5). After 2 h of pretreatment with either CO (0–500 ppm) or air, 
LPS (Sigma-  Aldrich), peptidoglycan (Fluka), Pam3CSK4 (InvivoGen), 
poly(I:C) (GE Healthcare), fl  agellin (InvivoGen), or CpG oligonucleotide 
was added to the culture media and the culture plates were returned to 
the chambers.
Transfection. RAW 264.7 cells were stably transfected with a pSFFV/
HO-1 plasmid construct as described previously (5).
Mouse strains. C57BL/6 wild-type mice and gp91phox-defi  cient  mice 
(C57BL/6 background) were purchased from The Jackson Laboratory. 
HO-1–defi  cient mice were provided by S.-F. Yet (Brigham and Women’s 
Hospital, Boston, MA; reference 53). TLR3-defi  cient mice were derived as 
described previously (54). Animals were housed according to guidelines 
from the American Association for Laboratory Animal Care and Research 
Protocols and were approved by the Animal Care and Use Committee 
  (University of Pittsburgh School of Medicine).
Sucrose-gradient raft fraction. Sucrose-gradient raft fractions were sepa-
rated as described previously (55). In brief, cells were lysed in ice-cold MBS 
buff  er (25 mM MES, pH 6.5, 150 mM NaCl, 1% Triton X-100, 1 mM 
Na3VO4, and protease inhibitors). Lysates were adjusted to 4 ml of 40% 
  sucrose by mixing with 2 ml of 80% sucrose and overlaid with 4 ml of 35% 
sucrose and 4 ml of 5% sucrose in MBS buff  er. Samples were ultracentri-
fuged at 39,000 rpm for 18 h and fractionated into 12 subfractions.
Cytokine analysis. Media were analyzed with ELISA kits purchased 
from R&D Systems.
RNA quantifi  cation. Real-time PCR analysis was performed as de-
scribed previously (56). mRNA expression was quantifi  ed by SYBR Green 
two-step, real-time RT-PCR for IFN-β. The sequence of the primer for 
IFN-β is 5′A  G  C  T  C  C  A  A  G  A  A  A  G  G  A  C  G  A  A  C  A T , 3′G  C  C  C  T  G  T A  G  G  T  G  A-
G  G  T  T  G  A  T  C  T   (18). The expression of each gene was normalized to 
GAPDH mRNA content and calculated relative to control.
Electrophoretic mobility shift assay and NF-κB transcription factor 
assay. Nuclei extraction and electrophoretic mobility shift assay was per-
formed as described previously (19). A double-stranded oligonucleotide 
containing the consensus transcription factor–binding site for NF-κB was 
purchased from Promega. p65 NF-κB transcriptional activity was also 
  analyzed with ELISA-based kits purchased from Active Motif.
Immunoblotting and Immunoprecipitation. The rabbit anti-TLR4, 
TRAF-6, TRAF-2, IL-1 receptor–associated kinase 1, CD-14, and MD-2 
were purchased from Santa Cruz Biotechnology, Inc. The rabbit anti-p65, 
total Iκ-B, and IRF-3 were purchased from Cell Signaling Technology. The 
rabbit anti-TRIF and TLR9 were purchased from Abcam. The rabbit anti-
MyD88 was purchased from Chemicon. The rabbit anti-TLR3 and HO-1 
were purchased from StressGen Biotechnologies. The mouse anti–fl  otillin-1, 
p47phox, and gp91phox were purchased from BD Biosciences. CTx B Subunit 
peroxidase conjugate was purchased from Sigma-Aldrich. Immunoprecipita-
tion and SDS-PAGE was performed as described previously (55, 57).
Immunofl  uorescence and confocal microscopy. After incubation with 
TLR ligands, the cells were washed with serum-free medium and incubated 
with 8 μg/ml FITC-conjugated CTx B (FITC-CTx; Sigma-Aldrich) on ice 
for 10 min. After fi  xation and permeabilization, cells were stained with the 
rabbit anti-TLR3 or anti-TLR4 (Santa Cruz Biotechnology, Inc.). After 
washing, samples were incubated with Alexa 594–coupled secondary anti-
body for 1 h (55). For raft-aggregation experiments, cells were incubated 
with 8 μg/ml FITC-CTx on ice for 10 min, followed by incubation with 
4 μl/ml goat anti-CTx (Calbiochem) for 15 min at 4 or 37°C (23). Cells 
were placed on ice and washed with cold PBS and then fi  xed, permeabilized, 
and stained with anti-TLR3 or anti-TLR4, as described above. For analyz-
ing ROS, the cells were preincubated with 10 μM CM-H2DCFDA (Invit-
rogen) for 30 min, followed by incubation with TLR ligands (31). Samples 
were viewed with an Olympus Fluoview 300 Confocal Laser Scanning head 
with an Olympus IX70 inverted microscope, as described previously (55). 
Fluorescence intensity of cells exposed with CM-H2DCFDA was analyzed 
by Olympus Fluoview (V. 3.1.16) software from Olympus Optical Co.
Immunocytochemistry. Livers and kidneys were fi  xed, embedded, and 
serially sectioned (5 μm) in toto. Paraffi   n-embedded tissues were hydrated, 
retrieved, and immunostained with anti–TNF-α (BD Biosciences) and 
monoclonal anti–CI:A3-1(RDI) for macrophage staining. Bound primary 
antibodies were visualized with diaminobenzidine staining by using ABC 
kits (Vector Laboratories).
Preparation of membrane fraction and assay of superoxide anion 
production. Membrane fraction was isolated as described previously (58). 
The protein (1 mg/ml protein) was incubated with 1.2 mg/ml acetylated 
cytochrome C, 1 mg/ml NADPH in the presence or absence of 1 mg/ml 
superoxide dismutase for 20 min at 37°C. The reactions were read at 
550 nm, subtracting the A550 of the reaction containing superoxide dis-
mutase. The production of superoxide was calculated assuming an extinction 
coeffi   cient of 21 mM−1 cm−1 for reduced cytochrome C and normalized for 
mg protein and reaction time. Values were expressed as fold increase over 
control value.
Cytochrome b558 isolation and spectral analysis. Fresh bovine 
  peripheral blood was harvested and the neutrophils were isolated by using 
the erythrocyte-granulocyte fraction. Bovine cytochrome b558 was prepared 
as described previously (59). Isolated cytochrome b558 was analyzed on 
a double beam recording spectrophotometer (Shimadzu UV2501-PC). 
After determination of oxidized spectra, the sample cuvette was degassed 
and replaced with an atmosphere of argon. To obtain reduced spectra, the 
cuvette was injected through the septum with sodium dithionite solution 2388  INHIBITION OF TLR TRAFFICKING TO LIPID RAFTS BY CO | Nakahira et al.
(5 mM). To obtain CO spectra, 100% CO was bubbled into the cu-
vette through a septum for 30 s. Corresponding diff  erence spectra were 
digitally generated.
Statistical analysis. We performed statistical analysis by using an unpaired 
Student’s t test. All Data are mean ± SD from three diff  erent experiments. 
We considered values of P < 0.05 to be statistically signifi  cant.
Online supplemental material. Fig. S1 shows the immunofl  uorescence 
image of TLRs after cross-linking with anti-CTx antibody in macrophages. 
Fig.S2 shows spectral analysis of cytochrome b558 isolated from bovine 
  neutrophils. The online supplemental material is available at http://www.
jem.org/cgi/content/full/jem.20060845/DC1.
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